CD123 target validation and preclinical evaluation of ADCC activity of anti-CD123 antibody CSL362 in combination with NKs from AML patients in remission

por Xie, L H, Biondo, M, Busfield, S J, Arruda, A, Yang, X, Vairo, G, Minden, M D
Publicado 2017